PharmiWeb.com - Global Pharma News & Resources
31-Jan-2019

Bausch Health Reduces Debt By Additional $100 Million

LAVAL, Quebec, Jan. 29, 2019 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company" or "we") today announced it has paid down an additional $100 million of its senior secured term loans using cash generated from operations.

"As Bausch Health pivots to offense in 2019, we continue to remain committed to reducing our overall debt using cash flow generated from operations," said Joseph C. Papa, chairman and CEO, Bausch Health.

About Bausch Health
Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. More information can be found at www.bauschhealth.com.

Caution Regarding Forward-Looking Information and "Safe Harbor" Statement
This news release may contain forward-looking statements, which may generally be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," "target," or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to risks and uncertainties discussed in the Company's most recent annual and quarterly reports and detailed from time to time in the Company's other filings with the Securities and Exchange Commission and the Canadian Securities Administrators, which factors are incorporated herein by reference. Readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. Bausch Health undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this news release or to reflect actual outcomes, unless required by law.

Investor Contact:                                                                                 

Media Contact:

Arthur Shannon                                                                                  

Lainie Keller

arthur.shannon@bauschhealth.com            

lainie.keller@bauschhealth.com

(514) 856-3855                                                         

(908) 927-0617

(877) 281-6642 (toll free)           

 

Editor Details

Related Links

Last Updated: 31-Jan-2019